Global Veterinary Immunomodulators Market Research Report 2026(Status and Outlook)
Veterinary Immunomodulators are substances or drugs used to regulate or modify the immune system of animals. They are typically used in veterinary medicine to enhance or suppress the immune response in animals that are suffering from immune-related disorders or infections. Immunomodulators can help boost the animal's ability to fight infections, control autoimmune diseases, or regulate allergic reactions. They are often prescribed when an animal's immune system is either underactive (leading to infections) or overactive (leading to autoimmune or inflammatory diseases).
The global Veterinary Immunomodulators market size was estimated at USD 1172.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Veterinary Immunomodulators market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Veterinary Immunomodulators market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Veterinary Immunomodulators market.
Global Veterinary Immunomodulators Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zoetis, Inc.
Elanco Animal Health
Boehringer Ingelheim Animal Health
MSD Animal Health
ImmunoVet Ltd.
Vetoquinol S.A.
Phibro Animal Health Corporation
Ceva Sant? Animale
Biogenesis Bago
Market Segmentation (by Type)
Oral
Injectable
Topical
Others
Market Segmentation (by Application)
Online Sales
Offline Sales
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Veterinary Immunomodulators Market
Overview of the regional outlook of the Veterinary Immunomodulators Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary Immunomodulators Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Veterinary Immunomodulators, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Veterinary Immunomodulators market size was estimated at USD 1172.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Veterinary Immunomodulators market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Veterinary Immunomodulators market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Veterinary Immunomodulators market.
Global Veterinary Immunomodulators Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Zoetis, Inc.
Elanco Animal Health
Boehringer Ingelheim Animal Health
MSD Animal Health
ImmunoVet Ltd.
Vetoquinol S.A.
Phibro Animal Health Corporation
Ceva Sant? Animale
Biogenesis Bago
Market Segmentation (by Type)
Oral
Injectable
Topical
Others
Market Segmentation (by Application)
Online Sales
Offline Sales
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Veterinary Immunomodulators Market
Overview of the regional outlook of the Veterinary Immunomodulators Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary Immunomodulators Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Veterinary Immunomodulators, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Veterinary Immunomodulators
1.2 Key Market Segments
1.2.1 Veterinary Immunomodulators Segment by Type
1.2.2 Veterinary Immunomodulators Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VETERINARY IMMUNOMODULATORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Veterinary Immunomodulators Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Veterinary Immunomodulators Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VETERINARY IMMUNOMODULATORS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Veterinary Immunomodulators Product Life Cycle
3.3 Global Veterinary Immunomodulators Sales by Manufacturers (2020-2025)
3.4 Global Veterinary Immunomodulators Revenue Market Share by Manufacturers (2020-2025)
3.5 Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Veterinary Immunomodulators Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Veterinary Immunomodulators Market Competitive Situation and Trends
3.8.1 Veterinary Immunomodulators Market Concentration Rate
3.8.2 Global 5 and 10 Largest Veterinary Immunomodulators Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VETERINARY IMMUNOMODULATORS INDUSTRY CHAIN ANALYSIS
4.1 Veterinary Immunomodulators Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VETERINARY IMMUNOMODULATORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Veterinary Immunomodulators Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Veterinary Immunomodulators Market
5.7 ESG Ratings of Leading Companies
6 VETERINARY IMMUNOMODULATORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary Immunomodulators Sales Market Share by Type (2020-2025)
6.3 Global Veterinary Immunomodulators Market Size by Type (2020-2025)
6.4 Global Veterinary Immunomodulators Price by Type (2020-2025)
7 VETERINARY IMMUNOMODULATORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary Immunomodulators Market Sales by Application (2020-2025)
7.3 Global Veterinary Immunomodulators Market Size (M USD) by Application (2020-2025)
7.4 Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
8 VETERINARY IMMUNOMODULATORS MARKET SALES BY REGION
8.1 Global Veterinary Immunomodulators Sales by Region
8.1.1 Global Veterinary Immunomodulators Sales by Region
8.1.2 Global Veterinary Immunomodulators Sales Market Share by Region
8.2 Global Veterinary Immunomodulators Market Size by Region
8.2.1 Global Veterinary Immunomodulators Market Size by Region
8.2.2 Global Veterinary Immunomodulators Market Size by Region
8.3 North America
8.3.1 North America Veterinary Immunomodulators Sales by Country
8.3.2 North America Veterinary Immunomodulators Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Veterinary Immunomodulators Sales by Country
8.4.2 Europe Veterinary Immunomodulators Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary Immunomodulators Sales by Region
8.5.2 Asia Pacific Veterinary Immunomodulators Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Veterinary Immunomodulators Sales by Country
8.6.2 South America Veterinary Immunomodulators Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Veterinary Immunomodulators Sales by Region
8.7.2 Middle East and Africa Veterinary Immunomodulators Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VETERINARY IMMUNOMODULATORS MARKET PRODUCTION BY REGION
9.1 Global Production of Veterinary Immunomodulators by Region(2020-2025)
9.2 Global Veterinary Immunomodulators Revenue Market Share by Region (2020-2025)
9.3 Global Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Veterinary Immunomodulators Production
9.4.1 North America Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.4.2 North America Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Veterinary Immunomodulators Production
9.5.1 Europe Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.5.2 Europe Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Veterinary Immunomodulators Production (2020-2025)
9.6.1 Japan Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.6.2 Japan Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Veterinary Immunomodulators Production (2020-2025)
9.7.1 China Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.7.2 China Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zoetis, Inc.
10.1.1 Zoetis, Inc. Basic Information
10.1.2 Zoetis, Inc. Veterinary Immunomodulators Product Overview
10.1.3 Zoetis, Inc. Veterinary Immunomodulators Product Market Performance
10.1.4 Zoetis, Inc. Business Overview
10.1.5 Zoetis, Inc. SWOT Analysis
10.1.6 Zoetis, Inc. Recent Developments
10.2 Elanco Animal Health
10.2.1 Elanco Animal Health Basic Information
10.2.2 Elanco Animal Health Veterinary Immunomodulators Product Overview
10.2.3 Elanco Animal Health Veterinary Immunomodulators Product Market Performance
10.2.4 Elanco Animal Health Business Overview
10.2.5 Elanco Animal Health SWOT Analysis
10.2.6 Elanco Animal Health Recent Developments
10.3 Boehringer Ingelheim Animal Health
10.3.1 Boehringer Ingelheim Animal Health Basic Information
10.3.2 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Overview
10.3.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Market Performance
10.3.4 Boehringer Ingelheim Animal Health Business Overview
10.3.5 Boehringer Ingelheim Animal Health SWOT Analysis
10.3.6 Boehringer Ingelheim Animal Health Recent Developments
10.4 MSD Animal Health
10.4.1 MSD Animal Health Basic Information
10.4.2 MSD Animal Health Veterinary Immunomodulators Product Overview
10.4.3 MSD Animal Health Veterinary Immunomodulators Product Market Performance
10.4.4 MSD Animal Health Business Overview
10.4.5 MSD Animal Health Recent Developments
10.5 ImmunoVet Ltd.
10.5.1 ImmunoVet Ltd. Basic Information
10.5.2 ImmunoVet Ltd. Veterinary Immunomodulators Product Overview
10.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Product Market Performance
10.5.4 ImmunoVet Ltd. Business Overview
10.5.5 ImmunoVet Ltd. Recent Developments
10.6 Vetoquinol S.A.
10.6.1 Vetoquinol S.A. Basic Information
10.6.2 Vetoquinol S.A. Veterinary Immunomodulators Product Overview
10.6.3 Vetoquinol S.A. Veterinary Immunomodulators Product Market Performance
10.6.4 Vetoquinol S.A. Business Overview
10.6.5 Vetoquinol S.A. Recent Developments
10.7 Phibro Animal Health Corporation
10.7.1 Phibro Animal Health Corporation Basic Information
10.7.2 Phibro Animal Health Corporation Veterinary Immunomodulators Product Overview
10.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Product Market Performance
10.7.4 Phibro Animal Health Corporation Business Overview
10.7.5 Phibro Animal Health Corporation Recent Developments
10.8 Ceva Sant? Animale
10.8.1 Ceva Sant? Animale Basic Information
10.8.2 Ceva Sant? Animale Veterinary Immunomodulators Product Overview
10.8.3 Ceva Sant? Animale Veterinary Immunomodulators Product Market Performance
10.8.4 Ceva Sant? Animale Business Overview
10.8.5 Ceva Sant? Animale Recent Developments
10.9 Biogenesis Bago
10.9.1 Biogenesis Bago Basic Information
10.9.2 Biogenesis Bago Veterinary Immunomodulators Product Overview
10.9.3 Biogenesis Bago Veterinary Immunomodulators Product Market Performance
10.9.4 Biogenesis Bago Business Overview
10.9.5 Biogenesis Bago Recent Developments
11 VETERINARY IMMUNOMODULATORS MARKET FORECAST BY REGION
11.1 Global Veterinary Immunomodulators Market Size Forecast
11.2 Global Veterinary Immunomodulators Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Veterinary Immunomodulators Market Size Forecast by Country
11.2.3 Asia Pacific Veterinary Immunomodulators Market Size Forecast by Region
11.2.4 South America Veterinary Immunomodulators Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Veterinary Immunomodulators by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Veterinary Immunomodulators Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Veterinary Immunomodulators by Type (2026-2035)
12.1.2 Global Veterinary Immunomodulators Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Veterinary Immunomodulators by Type (2026-2035)
12.2 Global Veterinary Immunomodulators Market Forecast by Application (2026-2035)
12.2.1 Global Veterinary Immunomodulators Sales (K MT) Forecast by Application
12.2.2 Global Veterinary Immunomodulators Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Veterinary Immunomodulators
1.2 Key Market Segments
1.2.1 Veterinary Immunomodulators Segment by Type
1.2.2 Veterinary Immunomodulators Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VETERINARY IMMUNOMODULATORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Veterinary Immunomodulators Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Veterinary Immunomodulators Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VETERINARY IMMUNOMODULATORS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Veterinary Immunomodulators Product Life Cycle
3.3 Global Veterinary Immunomodulators Sales by Manufacturers (2020-2025)
3.4 Global Veterinary Immunomodulators Revenue Market Share by Manufacturers (2020-2025)
3.5 Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Veterinary Immunomodulators Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Veterinary Immunomodulators Market Competitive Situation and Trends
3.8.1 Veterinary Immunomodulators Market Concentration Rate
3.8.2 Global 5 and 10 Largest Veterinary Immunomodulators Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VETERINARY IMMUNOMODULATORS INDUSTRY CHAIN ANALYSIS
4.1 Veterinary Immunomodulators Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VETERINARY IMMUNOMODULATORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Veterinary Immunomodulators Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Veterinary Immunomodulators Market
5.7 ESG Ratings of Leading Companies
6 VETERINARY IMMUNOMODULATORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary Immunomodulators Sales Market Share by Type (2020-2025)
6.3 Global Veterinary Immunomodulators Market Size by Type (2020-2025)
6.4 Global Veterinary Immunomodulators Price by Type (2020-2025)
7 VETERINARY IMMUNOMODULATORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary Immunomodulators Market Sales by Application (2020-2025)
7.3 Global Veterinary Immunomodulators Market Size (M USD) by Application (2020-2025)
7.4 Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
8 VETERINARY IMMUNOMODULATORS MARKET SALES BY REGION
8.1 Global Veterinary Immunomodulators Sales by Region
8.1.1 Global Veterinary Immunomodulators Sales by Region
8.1.2 Global Veterinary Immunomodulators Sales Market Share by Region
8.2 Global Veterinary Immunomodulators Market Size by Region
8.2.1 Global Veterinary Immunomodulators Market Size by Region
8.2.2 Global Veterinary Immunomodulators Market Size by Region
8.3 North America
8.3.1 North America Veterinary Immunomodulators Sales by Country
8.3.2 North America Veterinary Immunomodulators Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Veterinary Immunomodulators Sales by Country
8.4.2 Europe Veterinary Immunomodulators Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary Immunomodulators Sales by Region
8.5.2 Asia Pacific Veterinary Immunomodulators Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Veterinary Immunomodulators Sales by Country
8.6.2 South America Veterinary Immunomodulators Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Veterinary Immunomodulators Sales by Region
8.7.2 Middle East and Africa Veterinary Immunomodulators Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VETERINARY IMMUNOMODULATORS MARKET PRODUCTION BY REGION
9.1 Global Production of Veterinary Immunomodulators by Region(2020-2025)
9.2 Global Veterinary Immunomodulators Revenue Market Share by Region (2020-2025)
9.3 Global Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Veterinary Immunomodulators Production
9.4.1 North America Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.4.2 North America Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Veterinary Immunomodulators Production
9.5.1 Europe Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.5.2 Europe Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Veterinary Immunomodulators Production (2020-2025)
9.6.1 Japan Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.6.2 Japan Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Veterinary Immunomodulators Production (2020-2025)
9.7.1 China Veterinary Immunomodulators Production Growth Rate (2020-2025)
9.7.2 China Veterinary Immunomodulators Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Zoetis, Inc.
10.1.1 Zoetis, Inc. Basic Information
10.1.2 Zoetis, Inc. Veterinary Immunomodulators Product Overview
10.1.3 Zoetis, Inc. Veterinary Immunomodulators Product Market Performance
10.1.4 Zoetis, Inc. Business Overview
10.1.5 Zoetis, Inc. SWOT Analysis
10.1.6 Zoetis, Inc. Recent Developments
10.2 Elanco Animal Health
10.2.1 Elanco Animal Health Basic Information
10.2.2 Elanco Animal Health Veterinary Immunomodulators Product Overview
10.2.3 Elanco Animal Health Veterinary Immunomodulators Product Market Performance
10.2.4 Elanco Animal Health Business Overview
10.2.5 Elanco Animal Health SWOT Analysis
10.2.6 Elanco Animal Health Recent Developments
10.3 Boehringer Ingelheim Animal Health
10.3.1 Boehringer Ingelheim Animal Health Basic Information
10.3.2 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Overview
10.3.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Market Performance
10.3.4 Boehringer Ingelheim Animal Health Business Overview
10.3.5 Boehringer Ingelheim Animal Health SWOT Analysis
10.3.6 Boehringer Ingelheim Animal Health Recent Developments
10.4 MSD Animal Health
10.4.1 MSD Animal Health Basic Information
10.4.2 MSD Animal Health Veterinary Immunomodulators Product Overview
10.4.3 MSD Animal Health Veterinary Immunomodulators Product Market Performance
10.4.4 MSD Animal Health Business Overview
10.4.5 MSD Animal Health Recent Developments
10.5 ImmunoVet Ltd.
10.5.1 ImmunoVet Ltd. Basic Information
10.5.2 ImmunoVet Ltd. Veterinary Immunomodulators Product Overview
10.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Product Market Performance
10.5.4 ImmunoVet Ltd. Business Overview
10.5.5 ImmunoVet Ltd. Recent Developments
10.6 Vetoquinol S.A.
10.6.1 Vetoquinol S.A. Basic Information
10.6.2 Vetoquinol S.A. Veterinary Immunomodulators Product Overview
10.6.3 Vetoquinol S.A. Veterinary Immunomodulators Product Market Performance
10.6.4 Vetoquinol S.A. Business Overview
10.6.5 Vetoquinol S.A. Recent Developments
10.7 Phibro Animal Health Corporation
10.7.1 Phibro Animal Health Corporation Basic Information
10.7.2 Phibro Animal Health Corporation Veterinary Immunomodulators Product Overview
10.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Product Market Performance
10.7.4 Phibro Animal Health Corporation Business Overview
10.7.5 Phibro Animal Health Corporation Recent Developments
10.8 Ceva Sant? Animale
10.8.1 Ceva Sant? Animale Basic Information
10.8.2 Ceva Sant? Animale Veterinary Immunomodulators Product Overview
10.8.3 Ceva Sant? Animale Veterinary Immunomodulators Product Market Performance
10.8.4 Ceva Sant? Animale Business Overview
10.8.5 Ceva Sant? Animale Recent Developments
10.9 Biogenesis Bago
10.9.1 Biogenesis Bago Basic Information
10.9.2 Biogenesis Bago Veterinary Immunomodulators Product Overview
10.9.3 Biogenesis Bago Veterinary Immunomodulators Product Market Performance
10.9.4 Biogenesis Bago Business Overview
10.9.5 Biogenesis Bago Recent Developments
11 VETERINARY IMMUNOMODULATORS MARKET FORECAST BY REGION
11.1 Global Veterinary Immunomodulators Market Size Forecast
11.2 Global Veterinary Immunomodulators Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Veterinary Immunomodulators Market Size Forecast by Country
11.2.3 Asia Pacific Veterinary Immunomodulators Market Size Forecast by Region
11.2.4 South America Veterinary Immunomodulators Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Veterinary Immunomodulators by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Veterinary Immunomodulators Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Veterinary Immunomodulators by Type (2026-2035)
12.1.2 Global Veterinary Immunomodulators Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Veterinary Immunomodulators by Type (2026-2035)
12.2 Global Veterinary Immunomodulators Market Forecast by Application (2026-2035)
12.2.1 Global Veterinary Immunomodulators Sales (K MT) Forecast by Application
12.2.2 Global Veterinary Immunomodulators Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Veterinary Immunomodulators Market Size by Type (M USD)
Table 4. Global Veterinary Immunomodulators Market Size by Application
Table 5. Veterinary Immunomodulators Market Size Comparison by Region (M USD)
Table 6. Global Veterinary Immunomodulators Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Veterinary Immunomodulators Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Veterinary Immunomodulators Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Veterinary Immunomodulators Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Immunomodulators as of 2025)
Table 11. Global Market Veterinary Immunomodulators Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Veterinary Immunomodulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Veterinary Immunomodulators Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Veterinary Immunomodulators Sales by Type (K MT)
Table 27. Global Veterinary Immunomodulators Market Size by Type (M USD)
Table 28. Global Veterinary Immunomodulators Sales (K MT) by Type (2020-2025)
Table 29. Global Veterinary Immunomodulators Sales Market Share by Type (2020-2025)
Table 30. Global Veterinary Immunomodulators Market Size (M USD) by Type (2020-2025)
Table 31. Global Veterinary Immunomodulators Market Share by Type (2020-2025)
Table 32. Global Veterinary Immunomodulators Price (USD/KG) by Type (2020-2025)
Table 33. Global Veterinary Immunomodulators Sales (K MT) by Application
Table 34. Global Veterinary Immunomodulators Market Size by Application
Table 35. Global Veterinary Immunomodulators Sales by Application (2020-2025) & (K MT)
Table 36. Global Veterinary Immunomodulators Sales Market Share by Application (2020-2025)
Table 37. Global Veterinary Immunomodulators Market Size by Application (2020-2025) & (M USD)
Table 38. Global Veterinary Immunomodulators Market Share by Application (2020-2025)
Table 39. Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
Table 40. Global Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 41. Global Veterinary Immunomodulators Sales Market Share by Region (2020-2025)
Table 42. Global Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 43. Global Veterinary Immunomodulators Market Size by Region (2020-2025)
Table 44. North America Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 45. North America Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 47. Europe Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 50. South America Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 51. South America Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 54. Global Veterinary Immunomodulators Production (K MT) by Region(2020-2025)
Table 55. Global Veterinary Immunomodulators Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Veterinary Immunomodulators Revenue Market Share by Region (2020-2025)
Table 57. Global Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Zoetis, Inc. Basic Information
Table 63. Zoetis, Inc. Veterinary Immunomodulators Product Overview
Table 64. Zoetis, Inc. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Zoetis, Inc. Business Overview
Table 66. Zoetis, Inc. SWOT Analysis
Table 67. Zoetis, Inc. Recent Developments
Table 68. Elanco Animal Health Basic Information
Table 69. Elanco Animal Health Veterinary Immunomodulators Product Overview
Table 70. Elanco Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Elanco Animal Health Business Overview
Table 72. Elanco Animal Health SWOT Analysis
Table 73. Elanco Animal Health Recent Developments
Table 74. Boehringer Ingelheim Animal Health Basic Information
Table 75. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Overview
Table 76. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Boehringer Ingelheim Animal Health Business Overview
Table 78. Boehringer Ingelheim Animal Health SWOT Analysis
Table 79. Boehringer Ingelheim Animal Health Recent Developments
Table 80. MSD Animal Health Basic Information
Table 81. MSD Animal Health Veterinary Immunomodulators Product Overview
Table 82. MSD Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. MSD Animal Health Business Overview
Table 84. MSD Animal Health Recent Developments
Table 85. ImmunoVet Ltd. Basic Information
Table 86. ImmunoVet Ltd. Veterinary Immunomodulators Product Overview
Table 87. ImmunoVet Ltd. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. ImmunoVet Ltd. Business Overview
Table 89. ImmunoVet Ltd. Recent Developments
Table 90. Vetoquinol S.A. Basic Information
Table 91. Vetoquinol S.A. Veterinary Immunomodulators Product Overview
Table 92. Vetoquinol S.A. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Vetoquinol S.A. Business Overview
Table 94. Vetoquinol S.A. Recent Developments
Table 95. Phibro Animal Health Corporation Basic Information
Table 96. Phibro Animal Health Corporation Veterinary Immunomodulators Product Overview
Table 97. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Phibro Animal Health Corporation Business Overview
Table 99. Phibro Animal Health Corporation Recent Developments
Table 100. Ceva Sant? Animale Basic Information
Table 101. Ceva Sant? Animale Veterinary Immunomodulators Product Overview
Table 102. Ceva Sant? Animale Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ceva Sant? Animale Business Overview
Table 104. Ceva Sant? Animale Recent Developments
Table 105. Biogenesis Bago Basic Information
Table 106. Biogenesis Bago Veterinary Immunomodulators Product Overview
Table 107. Biogenesis Bago Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biogenesis Bago Business Overview
Table 109. Biogenesis Bago Recent Developments
Table 110. Global Veterinary Immunomodulators Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Veterinary Immunomodulators Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Veterinary Immunomodulators Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Veterinary Immunomodulators Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Veterinary Immunomodulators Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Veterinary Immunomodulators Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Veterinary Immunomodulators Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Veterinary Immunomodulators Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Veterinary Immunomodulators Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Veterinary Immunomodulators Market Size by Type (M USD)
Table 4. Global Veterinary Immunomodulators Market Size by Application
Table 5. Veterinary Immunomodulators Market Size Comparison by Region (M USD)
Table 6. Global Veterinary Immunomodulators Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Veterinary Immunomodulators Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Veterinary Immunomodulators Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Veterinary Immunomodulators Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Immunomodulators as of 2025)
Table 11. Global Market Veterinary Immunomodulators Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Veterinary Immunomodulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Veterinary Immunomodulators Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Veterinary Immunomodulators Sales by Type (K MT)
Table 27. Global Veterinary Immunomodulators Market Size by Type (M USD)
Table 28. Global Veterinary Immunomodulators Sales (K MT) by Type (2020-2025)
Table 29. Global Veterinary Immunomodulators Sales Market Share by Type (2020-2025)
Table 30. Global Veterinary Immunomodulators Market Size (M USD) by Type (2020-2025)
Table 31. Global Veterinary Immunomodulators Market Share by Type (2020-2025)
Table 32. Global Veterinary Immunomodulators Price (USD/KG) by Type (2020-2025)
Table 33. Global Veterinary Immunomodulators Sales (K MT) by Application
Table 34. Global Veterinary Immunomodulators Market Size by Application
Table 35. Global Veterinary Immunomodulators Sales by Application (2020-2025) & (K MT)
Table 36. Global Veterinary Immunomodulators Sales Market Share by Application (2020-2025)
Table 37. Global Veterinary Immunomodulators Market Size by Application (2020-2025) & (M USD)
Table 38. Global Veterinary Immunomodulators Market Share by Application (2020-2025)
Table 39. Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
Table 40. Global Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 41. Global Veterinary Immunomodulators Sales Market Share by Region (2020-2025)
Table 42. Global Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 43. Global Veterinary Immunomodulators Market Size by Region (2020-2025)
Table 44. North America Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 45. North America Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 47. Europe Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 50. South America Veterinary Immunomodulators Sales by Country (2020-2025) & (K MT)
Table 51. South America Veterinary Immunomodulators Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Veterinary Immunomodulators Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Veterinary Immunomodulators Market Size by Region (2020-2025) & (M USD)
Table 54. Global Veterinary Immunomodulators Production (K MT) by Region(2020-2025)
Table 55. Global Veterinary Immunomodulators Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Veterinary Immunomodulators Revenue Market Share by Region (2020-2025)
Table 57. Global Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Veterinary Immunomodulators Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Zoetis, Inc. Basic Information
Table 63. Zoetis, Inc. Veterinary Immunomodulators Product Overview
Table 64. Zoetis, Inc. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Zoetis, Inc. Business Overview
Table 66. Zoetis, Inc. SWOT Analysis
Table 67. Zoetis, Inc. Recent Developments
Table 68. Elanco Animal Health Basic Information
Table 69. Elanco Animal Health Veterinary Immunomodulators Product Overview
Table 70. Elanco Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Elanco Animal Health Business Overview
Table 72. Elanco Animal Health SWOT Analysis
Table 73. Elanco Animal Health Recent Developments
Table 74. Boehringer Ingelheim Animal Health Basic Information
Table 75. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Overview
Table 76. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Boehringer Ingelheim Animal Health Business Overview
Table 78. Boehringer Ingelheim Animal Health SWOT Analysis
Table 79. Boehringer Ingelheim Animal Health Recent Developments
Table 80. MSD Animal Health Basic Information
Table 81. MSD Animal Health Veterinary Immunomodulators Product Overview
Table 82. MSD Animal Health Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. MSD Animal Health Business Overview
Table 84. MSD Animal Health Recent Developments
Table 85. ImmunoVet Ltd. Basic Information
Table 86. ImmunoVet Ltd. Veterinary Immunomodulators Product Overview
Table 87. ImmunoVet Ltd. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. ImmunoVet Ltd. Business Overview
Table 89. ImmunoVet Ltd. Recent Developments
Table 90. Vetoquinol S.A. Basic Information
Table 91. Vetoquinol S.A. Veterinary Immunomodulators Product Overview
Table 92. Vetoquinol S.A. Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Vetoquinol S.A. Business Overview
Table 94. Vetoquinol S.A. Recent Developments
Table 95. Phibro Animal Health Corporation Basic Information
Table 96. Phibro Animal Health Corporation Veterinary Immunomodulators Product Overview
Table 97. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Phibro Animal Health Corporation Business Overview
Table 99. Phibro Animal Health Corporation Recent Developments
Table 100. Ceva Sant? Animale Basic Information
Table 101. Ceva Sant? Animale Veterinary Immunomodulators Product Overview
Table 102. Ceva Sant? Animale Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ceva Sant? Animale Business Overview
Table 104. Ceva Sant? Animale Recent Developments
Table 105. Biogenesis Bago Basic Information
Table 106. Biogenesis Bago Veterinary Immunomodulators Product Overview
Table 107. Biogenesis Bago Veterinary Immunomodulators Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biogenesis Bago Business Overview
Table 109. Biogenesis Bago Recent Developments
Table 110. Global Veterinary Immunomodulators Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Veterinary Immunomodulators Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Veterinary Immunomodulators Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Veterinary Immunomodulators Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Veterinary Immunomodulators Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Veterinary Immunomodulators Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Veterinary Immunomodulators Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Veterinary Immunomodulators Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Veterinary Immunomodulators Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Veterinary Immunomodulators Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Veterinary Immunomodulators Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Veterinary Immunomodulators
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Veterinary Immunomodulators Market Size (M USD), 2025-2035
Figure 5. Global Veterinary Immunomodulators Market Size (M USD) (2020-2035)
Figure 6. Global Veterinary Immunomodulators Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Veterinary Immunomodulators Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Veterinary Immunomodulators Product Life Cycle
Figure 13. Veterinary Immunomodulators Sales Share by Manufacturers in 2025
Figure 14. Global Veterinary Immunomodulators Revenue Share by Manufacturers in 2025
Figure 15. Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Veterinary Immunomodulators Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Veterinary Immunomodulators Revenue in 2025
Figure 18. Industry Chain Map of Veterinary Immunomodulators
Figure 19. Global Veterinary Immunomodulators Market PEST Analysis
Figure 20. Global Veterinary Immunomodulators Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Veterinary Immunomodulators Market Share by Type
Figure 27. Sales Market Share of Veterinary Immunomodulators by Type (2020-2025)
Figure 28. Sales Market Share of Veterinary Immunomodulators by Type in 2025
Figure 29. Market Share of Veterinary Immunomodulators by Type (2020-2025)
Figure 30. Market Share of Veterinary Immunomodulators by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Veterinary Immunomodulators Market Share by Application
Figure 33. Global Veterinary Immunomodulators Sales Market Share by Application (2020-2025)
Figure 34. Global Veterinary Immunomodulators Sales Market Share by Application in 2025
Figure 35. Global Veterinary Immunomodulators Market Share by Application (2020-2025)
Figure 36. Global Veterinary Immunomodulators Market Share by Application in 2025
Figure 37. Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
Figure 38. Global Veterinary Immunomodulators Sales Market Share by Region (2020-2025)
Figure 39. Global Veterinary Immunomodulators Market Size by Region (2020-2025)
Figure 40. North America Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 43. North America Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Veterinary Immunomodulators Market Size by Country in 2024
Figure 45. U.S. Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Veterinary Immunomodulators Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Veterinary Immunomodulators Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Veterinary Immunomodulators Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Veterinary Immunomodulators Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 53. Europe Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Veterinary Immunomodulators Market Size by Country in 2024
Figure 55. Germany Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Veterinary Immunomodulators Sales Market Share by Region in 2024
Figure 67. Asia Pacific Veterinary Immunomodulators Market Size by Region in 2024
Figure 68. China Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 79. South America Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 80. South America Veterinary Immunomodulators Market Size and Growth Rate (M USD)
Figure 81. South America Veterinary Immunomodulators Market Size by Country in 2024
Figure 82. Brazil Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Veterinary Immunomodulators Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Veterinary Immunomodulators Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Veterinary Immunomodulators Market Size by Region in 2024
Figure 92. Saudi Arabia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Veterinary Immunomodulators Production Market Share by Region (2020-2025)
Figure 103. North America Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 106. China Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Veterinary Immunomodulators Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Veterinary Immunomodulators Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Veterinary Immunomodulators Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Veterinary Immunomodulators Market Share Forecast by Type (2026-2035)
Figure 111. Global Veterinary Immunomodulators Sales Forecast by Application (2026-2035)
Figure 112. Global Veterinary Immunomodulators Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Veterinary Immunomodulators
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Veterinary Immunomodulators Market Size (M USD), 2025-2035
Figure 5. Global Veterinary Immunomodulators Market Size (M USD) (2020-2035)
Figure 6. Global Veterinary Immunomodulators Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Veterinary Immunomodulators Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Veterinary Immunomodulators Product Life Cycle
Figure 13. Veterinary Immunomodulators Sales Share by Manufacturers in 2025
Figure 14. Global Veterinary Immunomodulators Revenue Share by Manufacturers in 2025
Figure 15. Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Veterinary Immunomodulators Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Veterinary Immunomodulators Revenue in 2025
Figure 18. Industry Chain Map of Veterinary Immunomodulators
Figure 19. Global Veterinary Immunomodulators Market PEST Analysis
Figure 20. Global Veterinary Immunomodulators Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Veterinary Immunomodulators Market Share by Type
Figure 27. Sales Market Share of Veterinary Immunomodulators by Type (2020-2025)
Figure 28. Sales Market Share of Veterinary Immunomodulators by Type in 2025
Figure 29. Market Share of Veterinary Immunomodulators by Type (2020-2025)
Figure 30. Market Share of Veterinary Immunomodulators by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Veterinary Immunomodulators Market Share by Application
Figure 33. Global Veterinary Immunomodulators Sales Market Share by Application (2020-2025)
Figure 34. Global Veterinary Immunomodulators Sales Market Share by Application in 2025
Figure 35. Global Veterinary Immunomodulators Market Share by Application (2020-2025)
Figure 36. Global Veterinary Immunomodulators Market Share by Application in 2025
Figure 37. Global Veterinary Immunomodulators Sales Growth Rate by Application (2020-2025)
Figure 38. Global Veterinary Immunomodulators Sales Market Share by Region (2020-2025)
Figure 39. Global Veterinary Immunomodulators Market Size by Region (2020-2025)
Figure 40. North America Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 43. North America Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Veterinary Immunomodulators Market Size by Country in 2024
Figure 45. U.S. Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Veterinary Immunomodulators Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Veterinary Immunomodulators Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Veterinary Immunomodulators Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Veterinary Immunomodulators Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 53. Europe Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Veterinary Immunomodulators Market Size by Country in 2024
Figure 55. Germany Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Veterinary Immunomodulators Sales Market Share by Region in 2024
Figure 67. Asia Pacific Veterinary Immunomodulators Market Size by Region in 2024
Figure 68. China Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 79. South America Veterinary Immunomodulators Sales Market Share by Country in 2024
Figure 80. South America Veterinary Immunomodulators Market Size and Growth Rate (M USD)
Figure 81. South America Veterinary Immunomodulators Market Size by Country in 2024
Figure 82. Brazil Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Veterinary Immunomodulators Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Veterinary Immunomodulators Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Veterinary Immunomodulators Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Veterinary Immunomodulators Market Size by Region in 2024
Figure 92. Saudi Arabia Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Veterinary Immunomodulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Veterinary Immunomodulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Veterinary Immunomodulators Production Market Share by Region (2020-2025)
Figure 103. North America Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 106. China Veterinary Immunomodulators Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Veterinary Immunomodulators Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Veterinary Immunomodulators Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Veterinary Immunomodulators Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Veterinary Immunomodulators Market Share Forecast by Type (2026-2035)
Figure 111. Global Veterinary Immunomodulators Sales Forecast by Application (2026-2035)
Figure 112. Global Veterinary Immunomodulators Market Share Forecast by Application (2026-2035)
